Egg and sperm donation occupy a unique place in reproductive medicine: an intimate act that sits at the intersection of altruism, autonomy, ethics, and regulation. In comparison with blood donation, the stakes are higher, involving medical intervention and the creation of life. Donation is often motivated not by financial gain but by empathy, solidarity, and the wish to give others a chance to form a family. As one donor told our team:
'I didn't do it for money. I did it because my sister went through infertility, and I saw what it did to her. If I could help someone else avoid that pain, why wouldn't I?'
This echoes Richard Titmuss' observations on blood donation: when societies support altruism, the act of giving can become embedded in culture, strengthening social trust. By contrast, when donation is undermined, through suspicion, over-regulation, or withdrawal of support, the supply falters, and both altruism and social benefit are eroded.
Recent parliamentary debates in the UK appear to have ignited concerns around egg donation. The discussions, which challenge the carefully measured consensus and driven and proven regulations governing financial compensation for donors, focus on restricting or even abolishing donor compensation on the grounds this might 'entice' or exploit women; this exposes an underlying paternalism. Donors, largely educated, and capable of informed decision-making, are framed not as autonomous individuals but as vulnerable subjects needing protection.
Parliamentary objections to egg donation fall into three recurring claims:
- Donors may be coerced.
- Their health may be compromised.
- The health of donor-conceived children may be compromised.
Each of these concerns deserves scrutiny. Drawing on ethical, legal, and sociological perspectives, we argue that paternalistic restrictions threaten the dignity of donors and the sustainability of reproductive donation programmes in the UK.
Protecting donors and donor-conceived people
In 2025, the Human Fertilisation and Embryology Authority (HFEA) maintains a clear position on donation, centred on transparency, safety, and support for both donors and recipients. Donors undergo thorough counselling, health screening, and staged consent, with the ability to withdraw at any point.
The HFEA has also proposed revisions to donor compensation to better reflect the financial and personal costs associated with donation and is pursuing reforms to modernise the 1990 Act, particularly around donor anonymity and consent (see BioNews 1216). Collectively, these developments underscore the HFEA's commitment to informed consent, patient safety, and balanced support throughout the donation process.
Donor-conceived individuals have the right to access identifiable information about their donor from the age of 18, reflecting the intrinsic value of knowing one's genetic origins and the role of genealogy in shaping identity. Long-term HFEA data demonstrate no evidence of harm beyond the baseline risks associated with assisted reproduction. This aligns with Professor Golombok's extensive longitudinal research, which shows that children conceived through gamete donation or surrogacy generally thrive, and that any mild adjustment difficulties observed, particularly in surrogacy contexts, are more closely linked to factors such as maternal wellbeing and openness about origins than to the mode of conception itself. Families who are transparent about donor conception tend to exhibit greater psychological wellbeing and stronger parent-child relationships.
Coercion concerns
In the UK, currently, egg donors receive £985 per cycle; sperm donors £45 per clinic visit. This is not 'payment' in a commercial sense but a compensatory model, carefully calibrated to cover travel, time, and lost earnings without constituting inducement.
MPs who propose scrapping compensation argue that even modest sums risk 'enticing' women, particularly students, to undergo invasive treatment. Yet this overlooks two realities.
- First, the disparity between donor compensation and recipient costs reflects not exploitation but the high cost of laboratory procedures, staff, regulation, and clinical care involved in every cycle.
- Second, removing compensation risks excluding donors who cannot afford unpaid time off work, thereby limiting diversity and skewing donation towards only those who are financially privileged enough to 'donate for free'.
Ironically, such measures could make donation less equitable, not more ethical. Furthermore, research with egg donors shows that they are not the 'vulnerable' individuals some MPs have imagined, but informed, reflective individuals exercising agency. Data reveal a striking profile: most UK egg donors are university undergraduates, postgraduates, or women in established employment.
When donors themselves speak, their motivations and reflections are clear. A postgraduate student donor put it simply: 'I read everything, I asked every question, and I understood the risks. I still chose to do it. That's my decision.'
Another, reflecting on the proposals to remove compensation, said: 'If you tell people, you don't trust them to make their own decisions, they'll just stop helping. And then everyone loses.'
These voices highlight the crux of the debate: whether we see donors as capable moral agents or as passive subjects to be safeguarded against their own decisions.
Paternalism and the sociology of distrust
At the heart of this debate lies paternalism: the interference with individual liberty for one's own good. John Stuart Mill argued that such interference is justified only to prevent harm to others, not to protect individuals from themselves. Modern theorists, including Joel Feinberg, have distinguished between 'soft' paternalism, acceptable when individuals lack relevant information, and 'hard' paternalism, which restricts choice even when individuals are fully informed.
When egg donors receive comprehensive counselling, transparent information, and follow-up care, restrictions on their autonomy fall squarely within hard paternalism: ethically unjustifiable and socially corrosive. Recent parliamentary debates reflect a 'nanny state' reflex, infantilising competent women under the guise of protection. Rather than guiding decision-making, these proposals risk coercion disguised as care.
Such paternalism also risks breeding distrust. When the state signals doubt in citizens' capacity for moral and informed decision-making, it erodes confidence in institutions and professionals. This could have tangible effects on gamete donation: fewer donors, longer waiting times, and greater inequities in access to treatment. With only about 2200 egg donation cycles annually in the UK, additional restrictions could drive more patients abroad to less regulated systems or deter them entirely.
Egg donation is not merely a clinical transaction, but a social contract grounded in trust and altruism: donors give, believing their agency will be respected; recipients hope, trusting in the generosity of others. Undermining that trust weakens both the donation system and the wider ethos of reproductive solidarity on which it depends.
A Better Way Forward
If policymakers genuinely wish to improve donor welfare, the answer is not restriction but support.
- Robust informed consent: already a hallmark of UK practice.
- Follow-up care.
- Transparency: ensuring donors fully understand medical, legal, and emotional implications.
- Fair compensation: maintaining accessibility for donors of all social backgrounds.
London Egg Bank's two-year wellbeing check initiative is a practical example of enhanced follow-up care to reinforce trust; a two-year post-donation wellbeing review, which includes a full fertility assessment with consultant input at no cost.
Such measures honour both altruism and autonomy, avoiding the pitfalls of paternalism while ensuring the sustainability of donation programmes.
Egg donation is an extraordinary act of generosity, grounded not in financial gain but in altruism, empathy, and solidarity, values that enrich not only recipients but the social fabric itself.
Parliamentary attempts to restrict donor autonomy through the language of 'protection' misrepresent donors and disregard evidence. By conflating compensation with commodification, policymakers overlook the delicate balance that sustains donation programmes.
In reproductive medicine, the ethical imperative is clear: respect informed choice, safeguard without controlling, and nurture altruism rather than erode it. Anything less risks losing not only today's donors but also tomorrow's trust.
As one donor so aptly put it: 'This is my choice, not Parliament's. I gave because I wanted to. And I would again; but only if you let me.'



